Nanfang Hospital, Southern Medical University: Stomach Neoplasms trials

The registry lists 23 Stomach Neoplasms studies with Nanfang Hospital, Southern Medical University as lead sponsor. 13 are open to participants now and 0 have results posted.

Phase 2 9Phase 3 4No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07603349Phase 2/3
• Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric CancerNot yet recruitingNCT07511894Phase 2
• Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric CancerRecruitingNCT07294638
• Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric TissueNot yet recruitingNCT07276854
• A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies ScreeningRecruitingNCT07032961
• Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric CancerRecruitingNCT07003334
• Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home ScenariosRecruitingNCT06848400Not applicable
• Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer TrialNot yet recruitingNCT06310473Phase 2
• Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscoreNot yet recruitingNCT06202716Phase 2
• Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscoreRecruitingNCT06157996Phase 2
• Dual-Port Laparoscopic Distal Gastrectomy for Gastric CancerRecruitingNCT05494086Not applicable
• OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap MethodRecruitingNCT05450835Not applicable
• A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric CancerRecruitingNCT04934618Phase 2
• Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric CancerActive, not recruitingNCT07622693
• Safety and Efficacy of OGT Method Versus the Traditional Overlap MethodCompletedNCT05442502
• Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric CancerStatus unknownNCT04850716
• Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer TrialStatus unknownNCT04744649Phase 2
• Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)Status unknownNCT03488446
• Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal MetastasisStatus unknownNCT03023436Phase 3
• Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal GastrectomyStatus unknownNCT03016026Phase 2
• Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly PatientsStatus unknownNCT02246153Phase 3
• Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric CancerStatus unknownNCT02085031Phase 2
• Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)Status unknownNCT01609309Phase 3